Loke, Y K, Ho, R, Smith, M, Wong, O, Sandhu, M, Sage, W and Singh, S (2013) Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride. Journal of Clinical Pharmacy and Therapeutics, 38 (5). pp. 405-415. ISSN 1365-2710
Full text not available from this repository. (Request a copy)Abstract
A recently published large, long-term randomized controlled trial (RCT) brought into question the safety of dutasteride after a significantly increased risk of 'cardiac failure' was noted in the dutasteride arm of the trial compared with placebo. Our objective was to perform a meta-analysis to assess the risk of cardiovascular adverse events with the use of dutasteride for the prevention or treatment of prostatic disease.
Actions (login required)
![]() |
View Item |